Abridge, a generative AI platform for clinical conversations, announced it raised a $250 million Series D investment.The round was co-led by Elad Gil and IVP, with participation from Bessemer Venture Partners, California Health Care…
Continue Reading
NHS England has launched a ‘common front door’, in partnership with Health Data Research UK, to give health researchers access to its secure data environment (SDE) network.
The online portal went live at the end…
The UK healthcare sector is at risk of falling behind other European countries in adopting AI, according to a pan-European study.
The report, produced by healthcare AI research and development company Corti and YouGov, shows…
What You Should Know:
– Guardant Health, a provider in precision oncology, and ConcertAI, a real-world evidence (RWE) and AI technology company in oncology, announced a strategic collaboration that will provide biopharmaceutical companies with access…
Continue Reading
NHS Shared Business Services (NHS SBS) is planning the formation of a new framework agreement for AI solutions in healthcare.
It will be named Healthcare Artificial Intelligence Solutions and will replace the frameworks for AI…
What You Should Know:
– Promise Bio, a startup transforming immune-mediated disease treatment with advanced precision medicine solutions, today announced its emergence from stealth with an $8.3 million seed investment.
– This funding will accelerate the development of…
Continue Reading
Wavegate Corporation, a company that makes neuromodulation technology for chronic pain management, has secured $26 million in a Series A funding round led by UCEA Capital Partners Ltd. WHAT IT DOES
The Louisiana-based company offers its…
We know that data is essential to the government’s plan for healthcare. But transitioning from analogue to digital is not merely a technical challenge, writes Reecha Sofat, chair of the Professional Record Standards Body …
Continue Reading
Pharmaceutical powerhouse Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of Eli Lilly and Company, announced the creation of a SGD$42 million digital health innovation hub in Singapore.The…
Continue Reading
Taylor Wirth, Partner at Barnes & Thornburg
Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. Should they pursue an initial public offering (IPO) to fuel their growth,…
Continue Reading
